CA2177567C - Antibiotic biomass animal feed compositions - Google Patents

Antibiotic biomass animal feed compositions Download PDF

Info

Publication number
CA2177567C
CA2177567C CA002177567A CA2177567A CA2177567C CA 2177567 C CA2177567 C CA 2177567C CA 002177567 A CA002177567 A CA 002177567A CA 2177567 A CA2177567 A CA 2177567A CA 2177567 C CA2177567 C CA 2177567C
Authority
CA
Canada
Prior art keywords
antibiotic
biomass
animal feed
feed
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002177567A
Other languages
French (fr)
Other versions
CA2177567A1 (en
Inventor
Bruce Dexter King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ducoa LP
Original Assignee
Ducoa LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ducoa LP filed Critical Ducoa LP
Priority claimed from PCT/US1993/011573 external-priority patent/WO1995014395A1/en
Publication of CA2177567A1 publication Critical patent/CA2177567A1/en
Application granted granted Critical
Publication of CA2177567C publication Critical patent/CA2177567C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention is an animal feed composition comprising (a) dried antibiotic biomass containing one or more polyene antibiotics selected from the group consisting of natamycin, amphotericin A and B, virgi niamycin, leucomycins, levorin, filimarsin, partricin, a nd cabimicina unseparated from the residual biomass solids and (b) an animal fe ed, wherein the amount of antibiotic present in said bio mass is sufficient to prevent fugal attack during storage. A preferred antibiotic is natamycin.

Description

WO 9i!14395 ~ PCTIU893/1IS93 ANTIBIOTIC BIOMASS ANIMAL FEED COMPOSITIONS
FIELD OF THE INVENTION
The invention relates to animal feed compositions containing antibiotic biomass.
sgo_uND of z~iE INVENT~aN
In purified form polyene antibiotics are affective antibiotic agents for a number of uses. Natamycin, also known as pimaricin or tennectin, is an effective antifungal agent. Carter, U.S. Patents 4,536,494 and 4,600,706, discloses that dry crystalline natamycin can be mixed with feed grain to enhance growth.
U.S. Patent 4,132,777 discloses use of aqueous suspensions of natamycin on ~ 5 animals to control diseases such as ringworm. U.S. Patent 4,950,477 discloses aqueous aerosol suspensions of pure polyenes, including natamycin, for control of various fungal diseases in humans and animals. Canadian Patent 684,259 discloses feed additives of Candida albicans fermentation product, with or without the inclusion of an antifungal agent such as nystatin or natamycin. U.K. Patent 2o Application 2,106,498 discloses the use of Smeptomyces SF-1(ASA), NC1B
11738 to produce a new tetraene and also natamycin. U.S. Patents 4,395,491 and 4,291,053 discloses the use in fodder of salinomyan in its biomass to growth of ruminants and pigs.
2 5 ~~~~r.~~
The invention is an animal feed additive composition consisting essentially of (a) a dried antibiotic biomass containing at least one polyene antibiotic selected from the group consisting of amphotericin A and B, virginiamycin, leucomycin, levorin, filimarisin, partricin, and trichomycin in admixture with (b) a non-toxic carrier 3 0 material, the weight ratio of antibiotic to carrier in the admixture being from 0.167 to 5, wherein said dried biomass prevents fungal attack of feed during storage.
DETAILED DESCRIPT10N OF THE iNVErrrInN
3 5 It has been found that for many uses, particularly in an animal feed mixture, it is not necessary to extract and purify the antibiotic from its biomass.
More _1_ ~~~~~6~
W O 95/14395 PC'TIITS93/11573 specifically, it has been found that the biomass from an antibiotic fermentation broth is a superior ingredient in animal feeds, particularly grain based feeds, such as poultry feed. Not only does the antibiotic biomass contain biologically effective quantities of an antibiotic to protect against fungal mycotoxin production, but it also contains significant nutrient values such as protein, trace compounds, etc., which are desirable for maximizing animal growth.
The animal feed compositions comprise an animal feed such as a cracked grain feed for chickens, turkeys, etc., and a biologically effective amount of an antibiotic, which is included within a nonviable antibiotic biomass.
1o Antibiotic biomass is produced by fermentation using a microorganism that releases an antibiotic. The antibiotic biomass is rendered nonviable by any suitable technique that permits the biomass to be used as an ingredient in animal feed.
The biomass comprises at least one of the following: (1) the cells of the antibiotic releasing organism, (2) antibiotic, (3) residual fermentation medium, (4) fermentation broth (e.g., an aqueousphase which typically includes by-products).
A biologically effective amount is the amount of biomass required to give adequate antifungal control and milumize mycotoxin production in the feed.
Adequate control means that the animal feed is protected against mycotoxins produced by fungi, mold, yeast, etc., over the entire storage period.
2o Animal feed is a foodstuff that is provided to animals, such as chickens, horses, poultry, swine, turkeys, ruminants (e.g., bovine), pets, etc. The foodstuff typically comprises cereal grains (e.g., corn), soybeans, oil seeds, etc., which have been crushed or ground. The antibiotic biomass may be admixed with the foodstuff before, during and/or after being crushed or ground to obtain the animal feed.
z5 Stored means any techluque whereby the animal feed is kept in a ready-to-use form for a prolonged period of time, namely 1 to at least 2 weeks. Storage may be in elevators, bins, bags, etc. Dried means that the nonviable antibiotic biomass, either sun dried or heat dried, has had its initial moisture content of about at least 30% by weight, decreased to about 15% or lower, normally about 7%.
3o Antibiotics useful in the antibiotic biomass include natamycin, amphotericin A and B, virginiamycin (staphylomycin), leucomycins, levorin, filimarsin, partricin, and cabirnicina (Trichomycinc~ ). These antibiotics are disclosed in a number of references well known to those skilled in the . art, such as the Antibiotics Annual. ' Amphotericin is described in Heineman, U.S. Patent 3,126,317. The antibiotic 35 biomass may include functional equivalent derivatives of the antibiotics that are produced in the fermentation broth. Although, the fermentation process for 217T~61 .WO 95114395 PCT/US93111573 obtaining these antibiotics are known, it was unexpected that the antibiotic biomass was a superior feed additive.

The biomass may also contain: inorganic chlorides, sulfates, phosphates and combinations thereof as salts of sodium, potassium, calcium, magnesium, etc; trace elements, such as boron, cobalt, iron, copper, zinc, manganese, chromium, molybdenum; and complex growth factors (e.g., vitamins).

The animal feed compositions are prepared by admixing, i. e., blending, etc., a biologically effective amount of dried antibiotic biomass with animal feed at a concentration of 0.5 to 100 g, typically 5 to 20 g, of antibiotic biomass per ton (907 to Kg) of feed. The amount of biomass added to the animal feed depends upon the environment of the feed. If the environment is favorable for fungal growth, a relatively large dosage of the antibiotic may be required to prevent fungal mycotoxin contamination, e.g., 50-80 g of antibiotic biomass per ton (907 Kg) of feed.

Favorable environments are those that are warm and moist, possess a neutral pH, i5 contain oxygen, and include a substrate that enhances fungi growth. Since the amount of antibiotic biomass required to prevent contamination is less than the amount of antibiotic biomass required to treat existing fungal growth, the antibiotic biomass should be added to the animal feed as soon as it becomes practicable.

Additional antibiotic may be added to the biomass to increase its 2 o effectiveness. The added antibiotic may be any pharmaceutically acceptable derivative of the antibiotic (e.g., calcium and sodium salts, and esters of antibiotic).

If desired, the effectiveness of the antibiotic biomass may be increased by comminuting or grinding the dried antibiotic biomass to increase the surface area of the antibiotic. The comminuted biomass is also more readily distributed throughout 2 5 the animal feed in a uniform manner.

For some applications it may be desirable to first prepare a concentrated premix comprising a compatible non-toxic carrier, such as rice hulls, limestone, soybean flour, corn cob fractions, etc., with a relatively large amount of the antibiotic biomass, such as 5-20 g of antibiotic per 1-5 pounds (0.454-2.25 Kg) of the 3 o non-toxic carrier. This premix may then be blended into feed, along to achieve the desired concentration of biomass in the animal feed composition.

The antibiotic biomass is produced by any conventional fermentation process using a microorganism that produces a desirable antibiotic.
During fermentation, the antibiotic producing organism culture is introduced into an aerated nutrient-rich 35 antibiotic production medium. The organisms propagate and produce an antibiotic.

WO 95114395 - . PCTIUS93I11573 Depending on fermentation conditions, antibiotic production rates normally are in the range of about 0.5 to 1.5 g/L antibiotic per liter of production medium.
One specific technique for obtaining a suitable antibiotic biomass comprises preparing (e.g., sporulation) and propagating an inoculum comprising an antibiotic releasing species that, during fermentation, produces the desired antibiotic.
The antibiotic releasing species is exposed to a series of predetermined environments and/or mediums which may improve the rate at which antibiotic is produced.
Any organism which comprises a natamycin producing Streptomyces species can be used in accordance with the invention to provide the natamycin biomass.
A
1o preferred Streptomyces species comprise Streptomyces gilvosporeus which has been deposited previously with the American Type Culture Collection (ATCC) in Rockville, Maryland, United States of America, that is registered as ATCC No.
13326.
The biomass is produced by fermentation. Antibiotic producing I5 microorganisms are propagated and introduced into an aerated nutrient-rich fermentation medium. The pH of the fermentation broth may be controlled (e.g., via addition of an alkali base), in a manner which improves the effectiveness of the fermentation process. If desired, the fermentation process may be operated in a continuous manner. Depending on fermentation conditions, antibiotic production 2 o yields normally are in the range of about 0.5 to 1.5 g of antibiotic per liter of production medium.
One specific technique for obtaining suitable natamycin biomass comprises preparing and propagating an inoculum comprising a Streptomyces species that, during fermentation, produces natamycin. The Streptomyces species is exposed to a 25 series of predetermined environments and/or mediums which improve the rate at which natamycin is produced.
By providing an improved environment for the Streptomyces species the yield of natamycin may be increased to values in the range of about S to 12 g/L. A
biomass having an increased quantity of natamycin can be obtained in a 3 o fermentation process by using the following inoculum propagation and fermentation media:
1. A suitable medium for inoculum propagation may be prepared in water (e.g., low mineral content water, distilled water, etc.), and comprises:
a. a protein nitrogen source in an amount of from about 2-16 g/L, s 5 normally about 8 g/L; and 2~~7~6~
~ W0 95/14395 PCT/US93/I 1573 b. a metabolizable carbon source present in an amount which is sufficient to avoid total carbon depletion, usually 5-30 g/L of medium, and normally about 15 g/L;
2. A suitable medium used during fermentation to induce the inoculum to produce natamycin comprises:
a. about 80-250 g/L of a metabolizable carbon source; and s b. a protein nitrogen source containing a high level of protein and trace ingredients. The protein nitrogen source typically comprises a non-yeast protein nitrogen component and a yeast protein nitrogen 1o component. These two protein nitrogen components are desirably present in a ratio ranging, respectively, from about 5:1 to 11:1 based on protein contents, and for best results about 8:1.
The protein nitrogen source may be supplied from a wide range of sources.
For example, soy protein products (e.g., isolates, flours, meals, etc.), may comprise the non-yeast protein nitrogen source (e.g., desirable natamycin biomass yields are obtained with a soy protein source comprising 80-95% protein).
The yeast protein nitrogen may also comprise beef extract, protein hydrolysates (e.g., peptones) and/or yeast (e.g., extracts, autolysates, etc.).
As discussed above, the production medium must also include a source of 2o carbon which is metabolizable by the Streptomyces species. The carbon source may be supplied in any expedient form such as glucose, polysaccharide, corn and potato starches, etc.
During fermentation, natamycin may precipitate out as a free crystal, and the same may be bound to the inside and/or on the outside surface of the cells of the organism being fermented. In most fermentations, the natamycin fraction of total biomass solids will be in the range of about 5 to 35% natamycin by dry weight of the resultant natamycin biomass product.
At the end of the fermentation the biomass, together with the natamycin, may be physically removed from the fermentation broth. Any solid-liquid 3 o separation technique may be used to separate the natamycin biomass from any liquid present (e.g., filtration, centrifugation, etc.). Alternatively, the fermentation broth may be concentrated by removal of water, such as by evaporation, chemical treatment, etc. The resulting concentrate of natamycin biomass retains all of the valuable nutrients and other desirable ingredients that might normally have been lost during filtration.
_5_ WO 95114395 ~ ~ ~ ~ ~ ~ ~ PCTIUS93111573 Following concentration, the natamycin biomass is dried by any suitable technique such as by spray dryer, fluid bed dryer, shelf dryer, etc. The temperature used for drying ranges from about 0 to 120 C and depends on the drying technique used and the thermal stability of natamycin to a given technique.
The natamycin fermentation, natamycin biomass recovery and treatment processes generally yield a natamycin biomass which contains about 5 to 35%
natamycin on a dry weight total natamycin biomass basis.
During fermentation, the antibiotic may precipitate out as a free crystal, and the same may be bound to the inside and/or on the outside surface of the cells of 1o the organism being fermented. In most fermentations, the antibiotic fraction of total biomass solids will be in the range of about 5 to 35% anri'biotic by dry weight of the resultant antibiotic biomass product.
At the end of the fermentation the biomass, together with the antibiotic, may be physically removed from the fermentation broth. Any solid-liquid separation technique may be used to separate the antibiotic biomass from any liquid present (e.g., filtration, centrifugation, etc.). Alternatively, the fermentation broth may be concentrated by removal of water, such as by evaporation, chemical treatment, etc.
The resulting concentrate of antibiotic biomass retains all of the valuable nutrients and other desirable ingredients that might normally have been lost during filtration.
2o Following concentration, the antibiotic biomass is dried by any suitable technique such as by spray dryer, fluid bed dryer, shelf dryer, etc. The temperature used for drying ranges from about 0 to 60 C and depends on the drying technique used and the thermal stability of the antibiotic to a given technique.
The antibiotic fermentation, antibiotic biomass recovery and treatment a5 processes generally yield antibiotic biomass containing about 25 to 35%
antibiotic on a dry weight total antibiotic biomass basis.
For example, the solids from a fermentation broth containing the antibiotic may be separated, for example, by centrifuging. The supernate may be discarded and the biomass divided into panicles. Biomass may be dried in a fluid bed dryer at 30 70 C until a moisture content of about 7-8% by weight is obtained. The dried antibiotic biomasses may be mixed with a chicken feed comprising corn, wheat and soybean meal at a rate of about 100 g of biomass per ton (907 Kg) of chicken feed.
Alternatively, a feed premix may be prepared by mixing about 100 g of the antibiotic biomasses with about 1-5 pounds (0.454-2.25 Kg) of rice hulls and/or soybean flour.
35 The premixes may be admixed with a chicken feed comprising corn, wheat and soybean meal to obtain an enhanced feed including about 10 to 15 g of antibiotic .WO 95114395 PCT/US93111573 per ton (907 Kg) of feed. The resultant feed is (1) protected from fungi contamination, (2) permits enhanced chicken growth rates and (3) controls and prevents diseases in the chicken associated with a fungi infection or mycotoxin production.
The antibiotic biomass is compatible with other additives which may be admixed with the animal feed. Suitable additives include: protein, fat, fiber, calcium (e.g., calcium carbonate), phosphorus, trace metals, vitamins, citrus pulp, grape hulls, rice hulls, etc. An energy source such as sugar (e.g., lactose) may already be present and/or admixed with the added antibiotic biomass. In addition to the 1o energy source, other materials may be used in conjunction with the antibiotic biomass. Fish meal, certain vitamins, etc., may be added to reduce the growth rate of the fungi. However these materials alone are not sufficient to protect animal feed from fungi contamination.
Depending upon the storage conditions, the antibiotic can be expected to be effective against fungal contamination of the animal feed for several weeks or months. However, to ensure maximum effectiveness, the feed composition should be shielded from extended exposure to light, e.g., stored in the dark within a dry container.
Any antibiotic in the feed composition consumed by the animal is normally 2 o not absorbed or retained within the animal. As a result, the antibiotic is generally not incorporated into the eggs and/or flesh of the animal and does not affect human consumption of any animal which has consumed the feed composition. However, animals which are exposed to the fungi may incorporate the fungi, and in some cases toxins thereof, into their eggs and flesh. These fungi may be harmful to humans which consume the eggs and/or flesh of contaminated animals and, accordingly, it is desirable to prevent any significant exposure of such animals to fungi.
It may be advantageous to introduce the antibiotic biomass in the animal feed in conjunction with other treatment processes and/or substances. More importantly, the antibiotic biomass does not preclude using the animal feed in 3 o conjunction with any medication, end use product or event (e.g., the antibiotic biomass may be fed to an animal undergoing a certain medical treatment).
~ INDUS IAL PpI,IC RIIITY
The invention provides an enhanced animal feed by adding an antibiotic ~ 35 biomass to the feed. The antibiotic biomass enhances the quality and nutritional WO 95114395 ~ ~' ~ ~ ~ ~ ~ PCT/US93II1573 integrity of the feed by reducing, if not eliminating, contamination of the feed associated with fungal growth and possible mycotoxin release.
Although the antibiotic within the antibiotic biomass may have some beneficial effect on the animal, the purpose of the present invention is to protect the feed itself from fungal contamination. However, an animal feed containing the antibiotic which is substantially free from fungal contamination, will enhance the r animal growth rate in a cost effective manner. The antibiotic biomass (1) enhances the quality of the feed which enhances the health and, thus, growth rate of the animal consuming the feed and (2) permits cost-effective storage of animal feed for to a longer period of time without spoilage or waste due to fungal contamination.

This example illustrates the preparation of an antibiotic biomass and its addition to animal feed to produce an antibiotic containing animal feed composition.
Agar slants were prepared using distilled water to which has been added the following:
3 g/L yeast extract (Difco 'Bacto" Yeast Extract) 3 g/L malt extract (Difco Malt Extract) 5 g/L peptone (Difco'Bacto" peptone) 10 g/L glucose 15 g/L agar.
The agar was sterilized at about 121 C for about 15 min.
An inoculum medium of the following composition was prepared in distilled water. The pH was adjusted to about 7.0 with potassium hydroxide.
20 g/L glucose 10 g/L sodium chloride 6 g/L corn steep liquor (PPM (brand), Corn Steep Liquid) 6 g/L peptone (Difco 'Bacto" peptone) 3 o The inoculum medium was sterilized at about 121 C for about 15 min.
Streptomyces gilvosporeus, American Type Culture Collection Registration No. 13326, was obtained from the American Type Culture Collection as a freeze-dried spore suspension and used as the culture source. The culture was held on the agar slants at about 25 C until the culture sporulated.
The agar slants sporulated heavily within about 10 days and were used after 10-20 days. Spores were scraped off these agar slants into the inoculum medium to _g_ ~

achieve a spore suspension concentration of about 108 CFU/mL. About 2 mL of the spore suspension was added to about 100 mL of the inoculum medium in a 500 mL baffled flask. The inoculum in the baffled flask was incubated for about 48 hrs.

at about 29 C and agitated at about 200 rpm on a rotary shaker.
After about 48 hrs.

, about 4 mL of this culture was added to about 200 mL of inoculum medium in a 1 L

baffled flask, to propagate the inoculum. This inoculum was then incubated for about an additional 24 hrs. at about 29 C and agitated at about 200 rpm on a rotary shaker. The inoculum thus produced was used to inoculate 8 L
of production medium.

io The natamycin production medium was of the following initial composition:

19.5 g/L soy protein isolate (ADM,'Profam" 5970) 4.5 g/L yeast extract (Stauffer, Type KAT) 0.2 mL defoamer (Mazu, DF 289) The production medium was prepared in distilled water in a 14 L fermenter and the pH was adjusted to about 7.6 with potassium hydroxide. The fermenter was sterilized for about 15 min at about 121 C. Glucose was sterilized separately as a 50% solution in distilled water.

Before inoculation, the production medium was heated to about 29 C and th e glucose was added to achieve an initial concentration of glucose of about 40 g/L.

2o An aeration rate of about 0.3 v/v-min. (volumes of air per volume of medium er p min) and an agitation rate of about 300 rpm was established for the fermenter.

The inoculum containing Streptomyces gilvosporeus, (ATCC Registration No.

13326), was added to the fermentation vessel until the fermentation vessel had an inoculum content of about 2% by volume. Glucose was added to the inoculum after about 40 hr of fermentation in order to maintain a glucose concentration of about 20 g/L glucose in the fermentation vessel. This was done by feeding glucose to the fermenting vessel at a rate of about 1 g/Lrhr. The agitation rate of the fermentation vessel was increased as necessary to maintain a dissolved oxygen level of about SO%

of air saturation.

3o Solids within the biomass formed may be separated from the fermentation broth by centrifugation. The supernate from the centrifugation may be discarded and the pellets broken up and dried in a fluid bed dryer (e.g., dried at about 70 C to ' obtain a 7-8% moisture content). Alternatively, solids may be separated from the fermentation broth by filtration on a Buchner funnel using Whatman No. 3 filter ' 35 paper. The filter cake from the filtration process may be dried (e.g., dried to about 30% moisture in a convection oven at about 70 C and then drying to about 6%

_g_ VVO 95!14395 PCTIUS93111573 moisture in a fluid bed dryer). Typically, a total of about 1-13 g of biomass is recovered of which about 8-16% is natamycin. Normally, the antibiotic biomass is mixed with conventional fresh cracked corn/wheat/soybean meal (e.g., conventional chicken or turkey feed mix), at a rate of about 100-800 g of product per ton (907 Kg) of feed mix..
EX_AM_PLE 2 This example illustrates inhibition of mold growth in an animal feed composition that contains an antibiotic biomass.
io Commercial -crumbled broiler starter chicken feed was ground in a laboratory grinder to a uniform particle size of approximately 0.5 mm. Sterile distilled water added to increase the moisture content of the feed to 15.5%
The feed was divided into two portions. The control feed was left untreated.
Antibiotic biomass containing natamycin, similar to that prepared in Example 1, was added to i5 the other portion and thoroughly mixed to produce an animal feed composition that contained 11 ppm of natamycin.
Five 25 g samples of each portion were added to 250 mL wide-mouth Erlenmeyer flasks. Each flask was stoppered with a two-hole rubber stopped.
Chmulative oxygen consumption was measured using a Micro-Oxymax respirometer 2 o (Columbus Instruments, Columbus, Ohio).
CUMULATIVE OXYGEN CONSUMPTION (micro-L) l~a~g~Incuh arinn No BiomassBiomass Added Day 1 IO 20 25 Day 2 138 132 Day 3 278 269 Day 4 429 391 Day 5 6,722 2,542 Day 6 37,493 14,888 Having described the invention, we now claim the following and their equivalents.
i

Claims (9)

What is claimed:
1. An animal feed additive composition consisting essentially of (a) a dried antibiotic biomass containing at least one polyene antibiotic selected from the group consisting of amphotericin A and B, virginiamycin, leucomycin, levorin, filimarisin, partricin, and trichomycin in admixture with (b) a non-toxic carrier material, the weight ratio of antibiotic to carrier in the admixture being from 0.167 to 5, wherein said dried biomass prevents fungal attack of feed during storage.
2. The composition of claim 1 containing 5 to 35 parts by weight of antibiotic per 100 parts by weight residual biomass solids.
3. The composition of claim 1 mixed with animal feed to contain about 0.5 g to 100 g antibiotic per ton of animal feed.
4. The composition of claim 3 wherein the animal feed is grain-based poultry feed.
5. An animal feed composition consisting essentially of (a) a dried antibiotic biomass containing at least one polyene antibiotic selected from the group consisting of amphotericin A and B, virginiamycin, leucomycin, levorin, filimarisin, partricin, and trichomycin unseparated from the residual biomass solids from fermentation of the antibiotic-producing organism in admixture with (b) an animal foodstuff, the amount of antibiotic in the admixture being sufficient to reduce contamination of the foodstuff with fungal growth and mycotoxin during storage.
6. The composition of claim 5 containing from 5 to 35 parts by weight of antibiotic per 100 parts by weight residual fermentation solids.
7. The composition of claim 5 containing about 0.5 g to 100 g antibiotic per ton of animal feed.
8. The composition of claim 7 wherein the animal feed comprises cracked grain-based poultry feed.
9. The method of preparing an animal feed consisting essentially of:
preparing at least one polyene antibiotic selected from the group consisting of amphotericin A and B, virginiamycin, leucomycins, levorin, filimarisin, patricin and trichomycin in a fermentation broth containing fermentation medium and organisms capable of producing said antibiotic; separating from the fermentation broth said antibiotic and other biomass solids including organisms; drying said antibiotic and biomass solids; and adding the dried antibiotic and biomass solids to an animal feed, the amount of antibiotic in the admixture being sufficient to reduce contamination of the foodstuff with fungal growth and mycotoxin during storage.
CA002177567A 1993-11-29 1993-11-29 Antibiotic biomass animal feed compositions Expired - Fee Related CA2177567C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/011573 WO1995014395A1 (en) 1992-01-28 1993-11-29 Antibiotic biomass animal feed compositions

Publications (2)

Publication Number Publication Date
CA2177567A1 CA2177567A1 (en) 1995-06-01
CA2177567C true CA2177567C (en) 2002-09-24

Family

ID=22237239

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002177567A Expired - Fee Related CA2177567C (en) 1993-11-29 1993-11-29 Antibiotic biomass animal feed compositions

Country Status (4)

Country Link
JP (1) JPH09511123A (en)
CA (1) CA2177567C (en)
DE (1) DE69329952T2 (en)
HK (1) HK1013784A1 (en)

Also Published As

Publication number Publication date
JPH09511123A (en) 1997-11-11
CA2177567A1 (en) 1995-06-01
DE69329952T2 (en) 2001-08-09
HK1013784A1 (en) 1999-09-10
DE69329952D1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
EP0035119B1 (en) Polyether compounds and their manufacture, resultant composition and the use of these products as medicaments or growth promoting agents in ruminants
US5266347A (en) Antibiotic biomass animal feed compositions
CN1148939A (en) Production of feedings for livestocks, poultry and aquatic livings by using industrial waste and EM bacteria
US5902579A (en) Natamycin-containing streptomyces biomass and its use in animal feed
US6761899B1 (en) Particulate animal feed supplements and processes for the preparation thereof
KR20000052237A (en) A method of manufacturing a feed composite ,which contains yellow earth and chitosan, for livestock and cultured fish
EP0730413B1 (en) Antibiotic biomass animal feed compositions
CA2177567C (en) Antibiotic biomass animal feed compositions
US4279894A (en) Streptomyces metabolite
US4164572A (en) Zinc bacitracin composition for use as a feed supplement and method for making the same
AU5731794A (en) Antibiotic biomass animal feed compositions
JP2001204397A (en) Feed additive for cultured fish and formula feed
EP0132349B1 (en) Antibiotic called "chloropolysporin", a process for its preparation, and its therapeutic and veterinary use
LV12340B (en) A method for producing food additive, food additive and the use of it
US4670260A (en) Antibiotic for animal feeds
PL131791B1 (en) Process for preparing novel antibiotic
CN111296683A (en) Monascus fermentation product and aquatic functional biological feed thereof
DE3511753A1 (en) USE OF EFOMYCINES AS A GROWTH SUPPORT, EFOMYCINE AND THEIR PRODUCTION
CN107361247B (en) Grass carp cultivation feed and cultivation method thereof
SE437917B (en) ANIMAL FEEDS INCLUDING A NEW CHEMICAL SOCIETY THAT PROMOTES GROWTH AND IMPROVES ANIMAL FEEDING APPROPRIATE
PL131763B1 (en) Process for preparing a-4696g antibiotic
KR20010019252A (en) Multipurpose feed additives and preparation method thereof
JPS6211A (en) Composition containing novel antibiotic substance planothiocin a or b
GB2027013A (en) Compound M.139603 from Streptomyces longisporoflavus, and its use in ruminants
US3891754A (en) Antibiotic ensanchomycin and process of producing the same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed